Видео с ютуба (Hnscc)

The 1975 - HNSCC

The 1975 - HNSCC
Phase II trial of pembrolizumab and cabozantinib in HNSCC

Phase II trial of pembrolizumab and cabozantinib in HNSCC
Underlying Biology of HPV-Positive and -Negative HNSCC

Underlying Biology of HPV-Positive and -Negative HNSCC
Long-Term Toxicity in HNSCC

Long-Term Toxicity in HNSCC
KEYNOTE-048: progression post next line for R/M HNSCC

KEYNOTE-048: progression post next line for R/M HNSCC
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations?

Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations?
Biology of Head and Neck Squamous Cell Cancer (HNSCC)

Biology of Head and Neck Squamous Cell Cancer (HNSCC)
CDKN2A and TP53 mutation in HPV-negative HNSCC

CDKN2A and TP53 mutation in HPV-negative HNSCC
Dr. Burtness on the Use of Biomarkers in Metastatic HNSCC

Dr. Burtness on the Use of Biomarkers in Metastatic HNSCC
Correlation of TMB with CDKN2A and TP53 mutation in HPV-negative HNSCC

Correlation of TMB with CDKN2A and TP53 mutation in HPV-negative HNSCC
Surgical Management of HNSCC

Surgical Management of HNSCC
Oncotarget: New HPV Assay to Predict HNSCC Treatment Response

Oncotarget: New HPV Assay to Predict HNSCC Treatment Response
Chemotherapy for Advanced HNSCC

Chemotherapy for Advanced HNSCC
Surgery for Locally Advanced HNSCC

Surgery for Locally Advanced HNSCC
Immune-Based Approaches in the Curative Setting of HNSCC

Immune-Based Approaches in the Curative Setting of HNSCC
The 1975 - The End // Hnscc

The 1975 - The End // Hnscc
Immunotherapy in HNSCC

Immunotherapy in HNSCC
Phase 1 results of NBTXR3 treatment for locally advanced HNSCC in elderly patients

Phase 1 results of NBTXR3 treatment for locally advanced HNSCC in elderly patients